|
Volumn 34, Issue 6, 1988, Pages 755-760
|
Evidence that DNA topoisomerase I is necessary for the cytotoxic effects of camptothecin
a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ACIVICIN;
AMPHOTERICIN B;
AMSACRINE;
BISANTRENE;
CAMPTOTHECIN;
CAMPTOTHECIN DERIVATIVE;
CINERUBIN A;
CONGOCIDINE;
DACTINOMYCIN;
DAUNORUBICIN;
DNA TOPOISOMERASE;
DOXORUBICIN;
ELLIPTICINE;
ETOPOSIDE;
FOSTRIECIN;
HEDAMYCIN;
KANCHANOMYCIN;
MERBARONE;
MITOXANTRONE;
NYSTATIN;
RACHELMYCIN;
RAPAMYCIN;
RUFOCROMOMYCIN;
TENIPOSIDE;
UNCLASSIFIED DRUG;
CYTOTOXICITY;
DNA REPAIR;
DRUG SENSITIVITY;
FUNGUS;
MUTANT;
NONHUMAN;
PLASMID;
PRIORITY JOURNAL;
SACCHAROMYCES CEREVISIAE;
SCHIZOSACCHAROMYCES POMBE;
CAMPTOTHECIN;
DNA TOPOISOMERASES, TYPE I;
DNA TOPOISOMERASES, TYPE II;
DRUG RESISTANCE, MICROBIAL;
MUTATION;
SACCHAROMYCES CEREVISIAE;
SCHIZOSACCHAROMYCES;
SUPPORT, U.S. GOV'T, P.H.S.;
|
EID: 0024229066
PISSN: 0026895X
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (317)
|
References (0)
|